Portfolio company
Ability Biologics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
The company develops AI-engineered antibody biotherapeutics targeting autoimmune diseases and cancer for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ability Biologics
The company develops antibody biotherapeutics using artificial intelligence for patients with cancer, autoimmune and inflammatory diseases.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
Immunitas Therapeutics
This company develops antibody therapeutics for patients with cancer and autoimmune diseases.
AbCellera Biologics
The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
ai3Bio
This biotechnology company develops lipid nanoparticle and antibody platforms that selectively eliminate disease-causing cells to treat patients with autoimmune and inflammatory disorders.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Rhapsogen
This biotechnology company develops precision biologic therapeutics to treat autoimmune diseases by modulating antibody effector functions for patients with inflammatory conditions.